NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

AngioDynamics, Inc. (ANGO) Stock Analysis

AngioDynamics, Inc. (ANGO) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

ANGO

$15.20

−$0.27 (−1.75%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ANGO with… →

ANGO Key Statistics

As of Sep 4, 2026
Trading
Open
$15.36
Previous Close
$15.47
Day's Range
14.85–15.44
52-Week Range
9.39–16.29
Volume
527.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.33
Valuation
Market Cap
$628.25M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.41
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.96
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.86
Financials (FY)
Revenue (FY)
$320.17M+9.46%
Net Income (FY)
−$36.74M
Profit marginThe share of revenue left as profit after all costs and taxes.
−11.48%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
41.33M
1-Year Return
+41.66%
Dividend and dates
Earnings Date
October 1, 2026
Avg Volume
445.88K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ANGO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+18.38%
2025+40.17%
2024+16.84%
2023−43.06%
2022−50.07%
2021+79.91%
2020−4.25%
2019−20.47%
2018+21.05%
2017−1.42%
2016 (partial year)+8.91%

As of September 4, 2026.

ANGO Revenue and Earnings by Fiscal Year

FY ends May
Fiscal yearRevenueNet incomeNet margin
2025$320.17M−$36.74M−11.5%
2024$292.50M−$33.99M−11.6%
2023$303.91M−$184.35M−60.7%
2022$338.75M−$52.44M−15.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$320.17M$174.89M−$22.33M−$36.74M−11.5%
2024$292.50M$157.71M−$24.06M−$33.99M−11.6%
2023$303.91M$154.70M−$33.84M−$184.35M−60.7%
2022$338.75M$174.25M−$18.68M−$52.44M−15.5%

Annual figures as reported, in the company's reporting currency. As of May 31, 2026.

ANGO Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricANGOMedical Instruments & Supplies medianvs median
P/S ratio1.963.1738% below
Profit margin−11.48%0.85%12.3 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values AngioDynamics, Inc. (ANGO) at $628.25M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 632 employees.

ANGO last closed at $15.20 on September 4, 2026. That is −$0.27 (−1.75%) against the previous close. Over the past 52 weeks the price has ranged from $9.39 to $16.29. The latest close sits 61.87% above that 52-week low.

Financial Health

In fiscal 2025, AngioDynamics, Inc. reported revenue of $320.17M. That is +9.46% against the prior fiscal year, when revenue was $292.50M. The same year closed with a net loss of $36.74M. The reported profit margin is −11.48%. That is 12.3 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −0.86.

Across the 4 fiscal years on file, revenue moves from $338.75M in 2022 to $320.17M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.41. Measured against sales, the shares trade at 1.96 times revenue. On price-to-sales that is 38.15% below the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +41.66%. Measured over 10 years, that is −0.97% a year compounded. Beta against the wider market is reported at 0.33. Annualized volatility over the trailing 10 years is 47.99%.

Growth & Income

The record shows no dividend for ANGO.

The strongest complete calendar year on file is 2021 at +79.91%; the weakest is 2022 at −50.07%. Of the 9 complete calendar years on file, 4 finished higher. So far in 2026 the price is +18.38%.

Peer Comparison

AngioDynamics, Inc. (ANGO) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
AngioDynamics, Inc. ANGO $628.25M —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. AngioDynamics, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About AngioDynamics, Inc.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Visit website →